COVID-19: Bharat Biotech in preparation for booster dose, seeks approval for third clinical trial of its nasal vaccine
New Delhi, 20/12: Bharat Biotech has sent an application to DCGI for Phase III clinical trial of booster dose of Intranasal Covid Vaccine given through the nose. News agency ANI gave this information on Monday quoting its sources. The most important thing about this vaccine is that it can be given to all those people…
